Antibiotics are frequently used to treat severe chronic obstructive pulmonary disease (COPD). While the usual treatment for acute exacerbations of COPD (AECOPD) has traditionally been systemic steroids, there is ongoing discussion over the best way to dose and administer these drugs. The effectiveness of antibiotics is still debatable, with inconsistent findings from systematic reviews and clinical studies.
These inconsistent outcomes highlight the need for research into clinical indicators and biomarkers that can help identify patients who would benefit from antibiotics, sparing them for those who are unlikely to benefit and for whom antibiotic drawbacks (side effects, expense, and multi-resistance) should be avoided. To learn more about " Balancing Benefits & Risks: Antibiotic & Steroid Use in COPD Exacerbations " join Expert Pulmonologist Dr. Basha Khan in our exclusive webinar on…
